tbuckley/cabot-search huggingface dataset:
Pharmacodynamic Profiles of Patients (Pts) with Newly Diagnosed (ND) Vs Relapsed/Refractory Multiple Myeloma (RRMM) Who Received Teclistamab (Tec) or Talquetamab (Tal) Plus Daratumumab (Dara) and Lenalidomide (Len) in the Phase 1b Majestec-2 and Monumental-2 Studies
Authors: Diana Cortes, Brendan Paul Hodkinson, Ashwini Kumar, Sheri Skerget, Gary E Mason, Elizabeth Shearin, Hein Ludlage, Bas D Koster, Colleen Kane, Thomas Renaud, Tobias Kampfenkel, Christoph Heuck, Bhoomika Thakkar, Farheen Zishan, Emma Searle, Hang Quach, Gayathri Ravi, Cyrille Hulin, Wojciech Janowski, Jesus G Berdeja, Sébastien Anguille, Jeffrey V Matous, Cyrille Touzeau, Anne-Sophie Michallet, Ajay K. Nooka, Tara Cochrane, Anita D'Souza, Peter M. Voorhees, Karthik Ramasamy, Aurore Perrot, Andrew Spencer, Gurdeep Parmar, Deeksha Vishwamitra
Journal: Blood (2024)
A Phase I Study of CD19 CAR T-Cells with Escalating Doses of Lymphodepletion with or without Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Authors: Naseem S. Esteghamat, Joseph M Tuscano, Brian A. Jonas, Aaron S. Rosenberg, Rasmus T. Hoeg, Francisco Andres Socola, Brian Fury, Jordan Pavlic, Geralyn Annett, Jan A. Nolta, Mehrdad Abedi
Journal: Blood (2024)
<i>In Vitro</i> Drug Profiling to Guide Treatment for Relapse/Refractory AML
Authors: Stephen Lam, Andrew Chung-Hin Poon, Koon C. Chan, Navrose Kaur Singh, Wing Lam, Ching-Man Wong, Chi Yeung Fung, Wing-Hei Lai, Ka Lam Nelson K. L. Ng, Anskar Y.H. Leung
Journal: Blood (2024)
Safety and Efficacy in Pediatric Patients with Relapsed/Refractory Classic Hodgkin Lymphoma Enrolled on an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin (E4412)
Authors: Christopher J. Forlenza, Opeyemi Jegede, Stephen M. Ansell, Christian Steidl, Yasodha Natkunam, David W. Scott, Neha Mehta-Shah, Jennifer E. Amengual, Peter D. Cole, Brad S. Kahl, Catherine S. Diefenbach
Journal: Blood (2024)
Trial in Progress - Alliance A051901 - Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (Nivo-MR2) Induction Followed By Lenalidomide and Nivolumab Maintenance in Primary Central Nervous System Lymphoma (PCNSL)
Authors: Alvaro J Alencar, Olivia Bobek, Neha Mehta-Shah, Narendranath Epperla, Christine Lu-Emerson, Sarah C. Rutherford, Adam J. Olszewski, Thomas Ollila, Samuel Singer, Travis Dockter, Susan M. Geyer, Lori Rosenstein, Macarena De La Fuente, Eric D. Hsi, Shira N. Dinner, James L. Rubenstein, Nancy L. Bartlett, John P. Leonard
Journal: Blood (2024)
Impact of Transfusion Dependency on Patients Diagnosed with Myelodysplastic Syndrome According to IPSS-M Risk Group
Authors: Elena Bechtold Javier, Helena Pomares, Sandra Castaño-Díez, Guillermo Ramil López, Ivan Martín, Ana Perez Gonzalez, Blanca Xicoy, Joan Bargay, Ferran Vall-Llovera Calmet, Tzu Hua Chen, Jordi Vila Bou, Clara Maluquer Artigal, Ines Zugasti, Mercedes Galiano, Shiomara Quiñones, Mar Tormo, Guadalupe Onate, Esther Alonso, Neus Ruiz Xiville, Lurdes Zamora, Jordi Esteve, Marina Diaz Beya, Anna Sureda Balari, Montserrat Arnan
Journal: Blood (2024)
Single-Cell Analysis Reveals Depletion of Antigen-Presenting Cell (APC) and IFN-Stimulated CD4 T Cell Populations in High-Risk Newly Diagnosed Multiple Myeloma Patients
Authors: Junia Vieira, Alison S Park, David Melnekoff, Tarek H. Mouhieddine, Alessia D'anna, Adolfo Aleman, Meghana Ram, Katerina Kappes, Mark Hamilton, George Mulligan, Arun P Wiita, Ajai Chari, Thomas Martin, Michael Slade, Li Ding, Ravi Vij, Brian Brown, Benjamin Tycko, Rena Feinman, David S. Siegel, Sundar Jagannath, Samir Parekh, Alessandro Lagana
Journal: Blood (2024)
Phase 3, Randomized, Open-Label Study of Epcoritamab Plus Lenalidomide Compared with Rituximab Plus Gemcitabine and Oxaliplatin in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Authors: Muhit Ozcan, Won Seog Kim, Huilai Zhang, Maria Bouzani, Zsolt Nagy, Hun Chuah, Gilles Salles, Edwin E. Jeng, Jiangeng Huang, Mariana Sacchi, Yajian Jiang, Adrian Minson
Journal: Blood (2024)
<i>Inhibition of the Sec61 Translocon Promotes Immunoglobulin Light Chain Dependent Cell Stress and Apoptosis: Therapeutic Implications for AL Amyloidosis</i>
Authors: Ricardo Antonia, Stephen Yu, Kurt Henderson, Manuel Zancanella, David W. Wyatt, Lucas M. Bush, Shenhav David, Athena Chen, Kyle Reusch, Orsolya Darst, Kristopher Sarosiek, Zijing Jane Zhu, Nina Oberbeck
Journal: Blood (2024)
De Novo DLBCL with Concurrent Monoclonal B-Cell Lymphocytosis CLL-Type Exhibits Biological Characteristics Similar to Richter Syndrome
Authors: Fernando Martín Moro, Miguel Alcoceba, Samuel Romero, Juan Marquet, David Alonso Castronuño, Beatriz Astibia Mahillo, Rafael Andreu, Rocío Pérez Alonso, Cristina De Ramón, Irene Solano, Eulalia Rodríguez Martín, Miguel Piris-Villaespesa, Ernesto Roldán Santiago, Jose A. Garcia-Marco, Dolores Subirá, Almudena Navarro Bailon, José Antonio Garcia Vela, Mónica García-Cosío, Javier López
Journal: Blood (2024)
To What Extent Have Post-Transplant Outcomes Improved Following the Introduction of Tyrosine Kinase Inhibitors in Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia? a Retrospective Nationwide Survey in Japan
Authors: Shuichi Mizuta, Tomotaka Ugai, Satoshi Nishiwaki, Noriko Doki, Takahiro Fukuda, Tetsuya Nishida, Yuta Katayama, Shuichi Ota, Yuta Hasegawa, Masatsugu Tanaka, Makoto Onizuka, Tatsuo Ichinohe, Koji Kawamura, Yoshiko Atsuta, Yasuyuki Arai
Journal: Blood (2024)
PEPN2312: A Pediatric Early Phase Clinical Trials Network (PEP-CTN) Phase 1 Trial of Imetelstat with Fludarabine/Cytarabine in Pediatric Patients with Relapsed/Refractory AML, MDS, or JMML
Authors: Alexandra McLean Stevens, Maureen M. O'Brien, Xiaowei Liu, Charles G Minard, Olga Militano, Joel M Reid, Shyamala Navada, Todd M Cooper, Sarah K. Tasian, Elizabeth Fox, Brenda J. Weigel
Journal: Blood (2024)
Phase II Study of Pedi-Crib: Mini-Hyper-CVD with Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric Patients with B-Cell Lineage Acute Lymphocytic Leukemia
Authors: David McCall, Amber Gibson, Miriam B. Garcia, Cesar Nunez, Michael E. Roth, Branko Cuglievan
Journal: Blood (2024)
Machine Learning for Prediction of Serious Infections in Patients with Treatment-Naïve Lymphoma; A Population-Based Study of 701 Patients from the North Denmark Region
Authors: Alexander Fuglkjær, Deniz Kenan Kilic, Mathias Holmsgaard Eskesen, Laurids Østergaard Poulsen, Carsten Utoft Niemann, Paw Jensen, Kirstine Kobberøe Søgaard, Mikkel Werling, Frederik Christensen, Mikkel Runason Simonsen, Izabela Ewa Nielsen, Tarec Christoffer El-Galaly
Journal: Blood (2024)
A Children's Oncology Group Clinical Trial of Long-Term Outcomes in Survivors of Down Syndrome-Associated Acute Leukemia (ALTE22C1): <i>Clinical Trial in Progress</i>
Authors: Maria Monica Gramatges, Lauren N Sanclemente, Lacey Hall, Danielle L Mitchell, Olga A Taylor, Tanya Shannon, Tyler Brown, Michelle M Nuño, Smita Bhatia, Eric J. Chow, Kelly D. Getz, Johann K. Hitzler, Amanda M Li, Kaitlin McCloskey, Paul C Nathan, Maureen M. O'Brien, Serina Patel, Anupam Verma, Angela R Yarbrough, Geraldine Aubert, Tracie C Rosser, Lisa M Jacola, Philip J Lupo, Karen R Rabin
Journal: Blood (2024)
RP-L301, a Lentiviral-Mediated Gene Therapy for Pyruvate Kinase Deficiency (PKD): A Phase 2 Clinical Trial Design
Authors: Ami J Shah, José Luis López Lorenzo, Rachael F Grace, E J van Beers, M Bartels, Andreas Glenthoej, Susana Navarro, Lucia Llanos, Begoña Pérez de Camino Gaisse, Sol Sanchez, Josune Zubicaray, May Chien, Oscar Quintana Bustamante, M González-Vicent, June Iriondo, Miriam Zeini, Grace Choi, Eileen Nicoletti, Maria Chitty-Lopez, Gayatri R Rao, Juan Bueren, Jonathan D Schwartz, Jose Carlos Segovia, Julián Sevilla
Journal: Blood (2024)
A Phase 1, Open-Label, Dose Escalation and Dose Expansion, Multicenter Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Lomonitinib (ZE46-0134) in Adults with <i>FLT3</i>-Mutated Relapsed or Refractory Acute Myeloid Leukemia
Authors: Tara L. Lin, Kristin L Koenig, Ronan T. Swords, Eytan M. Stein, Maria R. Baer, Wendy Stock, Yazan F Madanat, Rebecca Olin, William Blum, Gary J. Schiller, Joshua F Zeidner, Emily K Curran, Molly Martycz, Leonard Rosenberg, Sonja Gullen Marcus, Timothy Chen, Mona Stefanos, Amy Burd, Ashley Owen Yocum, Ross L Levine, Brian J. Druker, Uma Borate, John C. Byrd, Alice Mims
Journal: Blood (2024)
Impact of Molecular Aberrations on Discordance Among Modalities of Blast Enumeration for Risk Stratification in Myelodysplastic Neoplasms
Authors: Laurenz Steiner, Navkirandeep Kaur, Johann-Christoph Jann, Alice Fabarius, Georgia Metzgeroth, Manja Meggendorfer, Wolf-Karsten Hofmann, Mohamad Jawhar, Daniel Nowak, Alexander Streuer
Journal: Blood (2024)
The Hypomethylating Agent 5-Aza-4‘-Thio-2‘-Deoxycytidine Targets Early B Progenitor Cells and Leads to B Cell Precursor Acute Lymphoblastic Leukemia in Rag1 Knockout Mice
Authors: Vijay Negi, Ryan Bertoli, Emily Muenzer, Peter D. Aplan
Journal: Blood (2024)
Trial in Progress: Phase I Trial Evaluating an Immunopeptidome-Defined Multi-Peptide Vaccine Against Acute Myeloid Leukemia Stem and Progenitor Cells
Authors: Susanne Jung, Annika Nelde, Yacine Maringer, Monika Denk, Lisa Zieschang, Christine Kammer, Melek Özbek, Christopher Hackenbruch, Jonas S. Heitmann, Helmut R. Salih, Juliane S. Walz
Journal: Blood (2024)
Addition of Anti-T-Lymphocyte-Globuline As Graft Versus Host Disease Prophylaxis for Matched Unrelated Donors Equalizes Outcomes with Matched Sibling Donors: Results from the AML SCT-BFM 2007 Trial
Authors: Martin G. Sauer, Peter Lang, Michael H Albert, Peter Bader, Ursula Creutzig, Matthias Eyrich, Johann Greil, Bernd Gruhn, Wolfgang Holter, Thomas Klingebiel, Bernhard Kremens, Christine Mauz-Körholz, Roland Meisel, Kirsten Mischke, Ingo Muller, Charlotte Marie Niemeyer, Christina Peters, Dirk Reinhardt, Birgit Burkhardt, Paul-Gerhardt Schlegel, Ansgar Schulz, Johanna Schrum, Petr Sedlacek, Brigitte Strahm, Wilhelm Woessmann, Rupert Handgretinger, Martin Zimmermann, Arndt Borkhardt
Journal: Blood (2024)
POIESIS: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Phase 3 Study of Navtemadlin As Add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Authors: Pankit Vachhani, Raajit Rampal, Terrence Bradley, Claire Harrison, Tania Jain, Andrew T. Kuykendall, Francesca Palandri, John O. Mascarenhas, Haifa Kathrin Al-Ali, Francesco Passamonti, Anna Nekhymchuk, Hilarie Foss, Wayne Rothbaum, Srdan Verstovsek, Florian Heidel
Journal: Blood (2024)
Enhancing Quality of Life in Myeloproliferative Neoplasms: Insights from Janus Kinase Inhibitors-a Comprehensive Review and Meta-Analysis
Authors: Moazzam Shahzad, Jawad Noor, Prashil Dave, Muhammad Fareed Khalid, Maheen Zaidi, Shriya Goyal, Ammad Naeem, Waleed Ahmed Mir, Iqra Anwar, Muhammad Kashif Amin, Michael V. Jaglal, Mohammad Ammad Ud Din, Turab Mohammad, Muhammad Salman Faisal
Journal: Blood (2024)
<i>Does Peripheral Blood Mirror Immune Tumor Microenvironment? Flow Cytometry Quantification of Peripheral Blood Lymphocyte Subpopulations and Outcomes in Patients with Diffuse Large B-Cell Lymphoma</i>
Authors: Luís Alberto de Pádua Covas Lage, Igor Cerejo Almeida, Cadiele Oliana Reichert, Giselle Groetares de Lima, Hebert Fabrício Culler, Fábio Alessandro de Freitas, Lilian de Souza França, Raphael Rodrigues da Costa, Paola Carolina Rabesquini Marcelino da Silva, Vanderson Rocha, Renata de Oliveira Costa, Sheila Aparecida Coelho da Siqueira, Juliana Pereira
Journal: Blood (2024)
Letermovir Prophylaxis Is Effective in Preventing CMV Reactivation and Is Associated with Decreased Non-Relapse Mortality in Two-Step Allogeneic Stem Cell Transplantation
Authors: Matthew J Tucker, Marc Yorker, Joanne Filicko-O'Hara, William O'Hara, Usama Gergis, Gina Keiffer, Xia Bi
Journal: Blood (2024)
Real-Word Effectiveness of Pacritinib in Patients with Myelofibrosis Who Have Thrombocytopenia and Anemia
Authors: Raajit Rampal, Michael Marrone, Lisa Morere, Abiola Oladapo, Purvi Suthar, Teena Sura, Anupama Vasudevan, Michael Vredenburg, Jia Zeng, John O. Mascarenhas
Journal: Blood (2024)
Optimal Timing and Impact of Allogeneic Peripheral Blood Stem Cell Transplantation in Adult T-Cell Lymphoblastic Lymphoma: Insights from a Large Cohort Multi-Center Real-World Study in Shanghai
Authors: Fangfang Yu, Jiahua Niu, Jianmin Yang, Jian Hou, Siguo Hao, Aibin Liang, Hong Xiong, Qi Zhu, Ligen Liu, Jun Shi, Juan Du, Bobin Chen, Rong Wei, Wenli Zhao, Lihua Sun, Yunhua Hou, Rong Tao, Xianmin Song
Journal: Blood (2024)
Comparative Analysis of Splanchnic Vein Thrombosis Prevalence and Clinical Relevance Versus Other Thromboses in Hispanic Patients with Myeloproliferative Neoplasms
Authors: Jessica Zalapa, Elena Juventina Tuna Aguilar, Laura Ceja Ramirez, Juan Rangel-Patiño, Angel Gabriel Vargas Ruiz, Martin Pacheco Serrano
Journal: Blood (2024)
Metronomic Low-Dose Regimen of Decitabine and Venetoclax Is Safe and Efficacious for Chronic Myelomonocytic Leukemia
Authors: Bradley Rockwell, Ioannis Mantzaris, Aditi Shastri, Kira Gritsman, R. Alejandro Sica, Noah Kornblum, Nishi Shah, David Levitz, Lauren Shapiro, Ridhi Gupta, Annemarie Munoz, Aradhika Dhawan, Karen Fehn, Monica Comas, Jhannine Verceles, Dennis L Cooper, Marina Konopleva, Eric J. Feldman, Amit Verma, Mendel Goldfinger
Journal: Blood (2024)
Identification of Light Chain Amyloidosis-Associated Single Nucleotide Variants in Japanese People
Authors: Shingen Nakamura, Youichi Sato, Yusaku Maeda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Hikaru Yagi, Shiro Fujii, Takeshi Harada, Masahiro Abe, Hirokazu Miki, Ken-ichi Matsuoka
Journal: Blood (2024)
STAT5-Activating Oncogenes Drive Oncostatin M Production Causing T Cell Exhaustion and Suppressive Myeloid Cell Recruitment
Authors: Michael Rassner, Tony Müller, Kirstyn Anne Crossley, Geoffroy Andrieux, Lena Jakob, Alina Müller-Rudorf, Natalie Koehler, Robert A. J. Oostendorp, Gerhard Müller-Newen, Katharina Schönberger, Nina Cabezas-Wallscheid, Irene Gonzalez-Menendez, Leticia Quintanilla-Fend, Olaf Groß, Oliver Gorka, Marie Follo, Anna Lena Illert, Melanie Boerries, Robert Zeiser, Justus Duyster
Journal: Blood (2024)
Pre-Hematopoietic Cell Transplantation (HCT) Frailty Is Associated with Lower Cognitive Function and Health-Related Quality of Life (HRQOL) in Older Adults Undergoing HCT
Authors: Thuy T Koll, Megan Kerns, Tanya M. Wildes, Vijaya Raj Bhatt, Krishna Gundabolu, Lori Maness, Michael Haddadin, Marcia Free, Elizabeth R Lyden, Daniel L Murman, Alfred L Fisher
Journal: Blood (2024)
Single-Cell Multi-Omics Analysis Reveals Autologous Stem Cell Chemo-Mobilization with Etoposide +Cytarabine Plus G-CSF in Multiple Myeloma
Authors: Zhijuan Zhu, Jiali Zhu, Xiaofan Li, Ming Zhu, Jinxian Dai, Jialiang Huang, Nainong Li
Journal: Blood (2024)
A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia
Authors: Suthesh Sivapalaratnam, Steve Austin, Ulrike Lorch, Matej Goricar, Gillian Lowe, Ashley Gosnell, Prafull S. Gandhi, Joseph Vogel, Jigar Amin, Andrew Law, Benny Sorensen, Catherine Rea
Journal: Blood (2024)
The Development of Acute Gvhd Under Steroid Administration Is a Risk Factor for Non-Relpase Mortality in Patients with Acute Gvhd after Allogeneic Hematopoietic Cell Transplantation
Authors: Tatsuya Suwabe, Takayuki Katagiri, Kyoko Fuse, Yasuhiko Shibasaki, Takashi Ushiki, Hirohito Sone, Masayoshi Masuko
Journal: Blood (2024)
Effect of Pre- and Peri-Transplant Measurable Residual Disease Clearance in Patients with Myelodysplastic Neoplasm; A Referral Center Experience
Authors: Ratdanai Yodsuwan, Sarah L Mott, Andrew Vegel, Aditya Ravindra, Prajwal Dhakal, Grerk Sutamtewagul, Margarida Magalhaes-Silverman, Kittika Poonsombudlert
Journal: Blood (2024)
Waning Long Term Efficacy of COVID-19 Post-Transplant Vaccination for Prevention of COVID-19 Adverse Events in Transplant and Cellular Therapy (TCT) Patients
Authors: Rahul Ramaswamy, Laith Fakhoury, Peter Zhao, Ningying Wu, Feng Gao, Geoffrey L. Uy, John F. DiPersio, Zachary D. Crees
Journal: Blood (2024)
The Parous Female Donor Is Not Inferior to Young Male Donor for Haploidentical Peripheral Blood Stem Cell Transplantation with Low-Dose ATG Plus Low-Dose Ptcy-Based Regimen for Gvhd Prophylaxis
Authors: Jingjing Cao, Chongmei Huang, Xingying Li, Yu Cai, Kun Zhou, Jun Yang, Xiaowei Xu, Huiying Qiu, Jiahua Niu, Ying Zhang, Xinxin Xia, Yu Wei, Chang Shen, Yin Tong, Baoxia Dong, Liping Wan, Xianmin Song
Journal: Blood (2024)
Risk of Depression and Anxiety Post Allogeneic Hematopoietic Stem Cell Transplant in Pediatric Patients with Cancer in a Low-Middle-Income Country (LMIC)
Authors: Sally Boshra, Hanafy Hafez, Mahmoud Hammad, Leslie E. Lehmann, Taghreed Mohamed, Nayera Hamdy, Ahmed Mosa, Alaa Elhaddad
Journal: Blood (2024)
Disease Bulk and/or Very High LDH As Adverse Factors in IPI 1-2 Diffuse Large B-Cell Lymphoma (DLBCL): A Hellenic Database Validation of the LEO Cohort
Authors: Theodoros P. Vassilakopoulos, Maria Panagiota Arapaki, Christina Apostolopoulou, Evgenia Verrou, Christina H. Kalpadakis, Alexia Piperidou, Athanasios Liaskas, Sotirios Sachanas, Theodora Triantafyllou, Aikaterini Bitsani, Maria Dimou, Maria Anastasia Ioakeim, Marina Siakantaris, Gerassimos Pangalis, Eirini Katodritou, Maria Angelopoulou, Panayiotis Panayiotidis, Vassiliki Pappa, Sotirios G. Papageorgiou
Journal: Blood (2024)
Hematopoietic Stem Cell Transplant for Acute Myeloid Leukaemia in Children and Adolescents: Multicentric Experience from India
Authors: Sunil Bhat, Sandeep Jain, Satya P Yadav, Garima Nirmal, Satyendra Katewa, Manas Kalra, Rhea Daruvala, Deena Dayalan, Velu Nair, Neha Rastogi, Shobha Badiger, Pooja Mallya, Ravi Joshi, Payal Malhotra, Dhwanee Thakkar, Rahul Sharma, Vaibhav Chadha, Anupam Sachdeva, Gauri Kapoor, Gaurav Kharya
Journal: Blood (2024)
Impact of Autoimmune Disease on Toxicity and Outcomes after Axicabtagene Ciloleucel in Patients with Diffuse Large B Cell Lymphoma
Authors: Anna Shamis, Rebecca Albuquerque, Athanasios Tsalatsanis, Ambuj Kumar, Zain Ahmad, Hasiq Ovais, Aleksandr Lazaryan, Farhad Khimani, Rawan Faramand, Ciara Louise Freeman, Bijal D Shah, Sameh Gaballa, Julio C. Chavez, Fabiana Perna, Jose L. Ochoa-Bayona, Frederick Locke, Michael D. Jain, Taiga Nishihori, Abu-Sayeef Mirza
Journal: Blood (2024)
Neighborhood-Level Social Determinants of Health and Cardiovascular Burden in Adolescent and Young Adult Patients Treated for Hodgkin Lymphoma
Authors: Elizabeth Rodriguez, Nader Kim El-Mallawany, Sairah Ahmed, Branko Cuglievan, John Andrew Livingston, Christopher R. Flowers, Qian Xiao, Michael E. Roth, Michelle A.T. Hildebrandt
Journal: Blood (2024)
SMART101 Donor T-Lymphoid Progenitors to Accelerate Immune Reconstitution Post HLA Mismatched Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide: Reset-02 First-in-Human Phase I/II
Authors: Raynier Devillier, Anne Huynh, Patrice Chevallier, Simona Piemontese, Regis Peffault de Latour, Patrizia Chiusolo, Aurelie Bauquet, Rahim Fandi, Sebastien Oster, Laura Simons, Isabelle Andre, Marina Cavazzana, Fabio Ciceri
Journal: Blood (2024)
Mutations in the Bruton Tyrosine Kinase (<i>BTK</i>) Gene in Patients with Chronic Lymphocytic Leukemia (CLL) Receiving BTK Inhibitors (BTKis)
Authors: Alan P Skarbnik, Alexey V. Danilov, Marc Hoffmann, Farrukh T. Awan, Frank Scarpa, Caryn Davies, Todd Oakland, Marina Kovach, Jenna Lilyquist, Veerendra Munugalavadla, Alan SM Yong, Vikram Shetty, John N. Allan, Jennifer A. Woyach
Journal: Blood (2024)
Evaluating the Effectiveness and Tolerability of Chimeric Antigen Receptor (CAR) T Cells Therapy in Patient with Systemic Lupus Erythematosus: A Systematic Review
Authors: Amirta Devi, Arun Kumar, Ranjit Sah, Sangam Shah, Amita Paudel, Sanjit Sah, Ghulam Shah, Ahda Solangi, Usama Mirza, Zeeshan Solangi
Journal: Blood (2024)
A Phase 1 Dose Escalation and Expansion Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Co-Stimulation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE-1)
Authors: Robert Weinkove, Philip George, Robert Fyfe, Aine Hurley, Nathaniel Dasyam, Yasmin Nouri, Tess Ostapowicz, Stefan Mullins, Giulia Giunti, Brittany Lavender, Brigitta Mester, Catherine M. Bollard, Travis Perera, Hayden Jina, Alwyn D'Souza, Le Qin, David S. Ritchie, Chris M.A. Frampton, Rachel Perret, Peng Li, Ian Hermans
Journal: Blood (2024)
Pola-Based Framework Regimen Treating DLBCL in Real World at Renji Hospital of China
Authors: Jun Du, Jue Wang, Zi-Yu Feng, Lan Xu, Fei Xiao, Jia Liu, Dan Xiao, Wan-Bin Fu, Min-Yue Zhang, Li-Jing Shen, Lu Zhong, Hua Zhong, Jian Hou, Hong-Hui Huang, Ting Wang
Journal: Blood (2024)
Fostering Collaborative Care in Multiple Myeloma: An Update on the Impact of Holistic Education on Decision-Making with Antibody and CAR-T Platforms
Authors: Carmine Deluca, Robert Z. Orlowski, Jennifer M. Ahlstrom, Beth M. Faiman, Irene Ghobrial, Michael Beyer, Marina Wanes, Abigail Brugger
Journal: Blood (2024)
Aplastic Anemia in the Elderly: Treatment Patterns and Outcomes from an International Observational Study
Authors: Bruno Fattizzo, Carmelo Gurnari, Sabrina Giammarco, Antony Ricchiuti, Hussein Awada, Marta Bortolotti, Giacinto Luca Pedone, Francesco Versino, Dario Consonni, Roochi Trikha, Shreyans Gandhi, Simona Sica, Jaroslaw Maciejewski, Austin G. Kulasekararaj, Wilma Barcellini
Journal: Blood (2024)
Real World Data of FLT3 Mutation Testing Rates Among Indian Patients with Acute Myeloid Leukemia: An AI-Enabled Intervention to Improve Guideline-Compliant Care
Authors: Lingaraj Nayak, Anant Gokarn, Prasanth Ganesan, Hari Menon, Nidhi Tandon, Naresh Ramarajan, Vishal Vashistha
Journal: Blood (2024)
Comparative Analysis of Treatment Outcomes in T-Cell Acute Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma: Implications for Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Youngwoo Jeon, Tong-Yoon Kim, Kyoung Il Min, Gi-June Min, Ki-Seong Eom, Jong Hyuk Lee, Seok-Goo Cho, Jae-Ho Yoon
Journal: Blood (2024)
Practice Patterns of SGLT2 Inhibitor Use in Stem Cell Transplantation and CART Cell Therapy: A Study from the EBMT Transplant Complications Working Party
Authors: Christian R Schultze-Florey, Mouad Abouqateb, Christophe Peczynski, William Boreland, Pascale Ambron, Alberto Mussetti, Christian Koenecke, Charlotte Graham, Helene Schoemans, Olaf Penack, Ivan Sergeevich Moiseev, Zinaida Peric
Journal: Blood (2024)
Effectiveness of Single-Dose Plerixafor in Enhancing Peripheral Blood Progenitor Cell Yield and Rate of Second Collection in Autologous Transplant
Authors: Gerardo Garcia-Salas, David Gomez-Almaguer, Carlos Reta-Cortéz, Antonio Vega Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, José Carlos Jaime-Pérez, César Homero Gutierrez-Aguirre, Luz Tarin-Arzaga, Perla Colunga-Pedraza, Olga Cantu, Andres Gomez-De Leon
Journal: Blood (2024)
Sintilimab Plus Gemcitabine, Cisplatin, and Dexamethasone As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma：a Multicenter Retrospective Study
Authors: Ruolan Zeng, Junqiao He, Yajun Li, Yizi He, Caiqin Wang, Chen Xia, Zhongtai Wang, Yixue Li, Yinhua Liu, Weiqiang Tang, Qianying Ouyang, Liang Liang, Chang Su, Guige Lu, Xueting Zhu, Qianyu Hu, Zhou Ouyang, Huijing Wu, Huilai Zhang, Ling Xiao, Hui Zhou
Journal: Blood (2024)
Outcomes of Patients with <i>IDH1/2</i> Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Era of IDH Inhibitors
Authors: Leah A Goldberg, James J. Yoon, Hannah Johnston, Marta Beata Davidson, Alexa Siddon, Rory M. Shallis, Evan C. Chen, Madelyn Burkart, Timothy S. Oh, Sunil G. Iyer, Ellen Madarang, Chandrasekar Muthiah, Joshua Kassner, Raajit Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin Abaza, Jacqueline S. Garcia, Vikas Gupta, Kristen M. Pettit, Olatoyosi Odenike, John F. Cursio, Anand Ashwin Patel
Journal: Blood (2024)